Eric Clapton said he had a “disastrous” health experience after receiving the AstraZeneca COVID vaccine, and the 76-year-old musician blamed propaganda for overstating the vaccine’s safety, Rolling Stone reported.
In February, Clapton said he took his first dose of AstraZeneca and immediately suffered severe reactions lasting 10 days. About six weeks later he was offered and took the second dose, but with a little more knowledge of the dangers.
“Needless to say the reactions were disastrous, my hands and feet were either frozen, numb or burning, and pretty much useless for two weeks. I feared I would never play again,” Clapton said. “But the propaganda said the vaccine was safe for everyone.”
Clapton suffers from peripheral neuropathy and said he should never have gotten the jab. Peripheral neuropathy occurs as a result of damage to the nerves outside of the brain and spinal cord (peripheral nerves). It often causes weakness, numbness and pain, usually in the hands and feet, and can also affect other areas of the body.
Clapton said he met a member of an online group who counseled him to be careful and look at what’s going on.
“I felt like a veil had been lifted, that I was no longer alone, that it was okay, in fact essential, to hold on to my intuition and follow my heart,” Clapton said. “I continue to tread the path of passive rebellion and try to tow the line in order to be able to actively love my family, but it’s hard to bite my tongue with what I now know,” he added.
The AstraZeneca vaccine is not authorized in the U.S., but three COVID vaccines — Pfizer, Moderna and Johnson & Johnson — are. The Centers for Disease Control and Prevention recommends even those people with weakened immune systems and underlying medical conditions be vaccinated for COVID despite what the CDC states is limited safety data for people who fall into those categories.
Vaccine makers running ad campaigns in hope of winning over non-takers
Days after Clapton’s criticism of vaccine “propaganda,” the Wall Street Journal reported on how, in the U.S., vaccine makers are sponsoring ad campaigns targeting the roughly one-third of Americans who are reluctant to get a COVID vaccine.
Unlike typical pharmaceutical ads that focus on specific drug brands, the COVID campaigns employ general messaging without mentioning manufacturers’ names. For example, some ads feature people spending time with loved ones, and end with “Why will you get vaccinated?”
One of Pfizer’s commercials shows a baby announcement as a reason to be vaccinated. According to iSpot, it was viewed 8.3 million times and had $78,000 in TV ad spend, the Wall Street Journal reported.
In another example, last month, late night host Jimmy Kimmel performed a skit in a white lab coat and answered medical questions about COVID vaccines that use mRNA technology. The skit was sponsored by vaccine maker Moderna.
Moderna declined to comment on its advertising budget but said the company increased marketing spending by $10 million during the first three months of 2021, compared to its 2020 first quarter.
Pfizer, Regeneron Pharmaceuticals Inc. (maker of a monoclonal antibody drug treatment) and Eli Lilly & Co. (maker of a rival antibody therapy) are running ads on TV, radio and social media platforms targeting people who use search engines in areas with high infection rates.
Regeneron spent about $545,000 on national TV ads related to COVID, and its commercial was seen 142.5 million times, according to iSpot.tv Inc., a TV ad-measurement firm.
Regeneron ran its first TV ad in late April just before the Academy Awards broadcast on ABC. The 30-second spot features actors repeating the phrase “monoclonal antibodies” in an attempt to familiarize the public with a term.
Lilly and Pfizer declined to say how much they have spent on COVID advertising.